Mary Kate Wold has held leadership positions in the pharmaceutical and life sciences, financial services, legal, and government sectors, including serving as a board director of numerous organizations. She is currently the CEO and a board member of the Church Pension Group (CPG), a pension and financial services company that is headquartered in New York City.
The Church Pension Group was incorporated in 1914 and manages a portfolio of $17 billion. CPG serves Episcopal clergy, lay employees, and institutions through the provision of pension and medical benefits, life and disability insurance, property and casualty insurance, and book and music publishing.
Prior to joining CPG, Ms. Wold was Senior Vice President, Finance, and a Principal Corporate Officer of Wyeth, one of the world’s largest research-based pharmaceutical companies. Sitting on several executive oversight committees, she provided direction across a spectrum of Wyeth’s business and finance operations.
Before Wyeth, Ms. Wold was a partner and chaired the tax practice group of Shearman & Sterling, one of the world’s leading law firms. She advised the firm’s global clients on cross-border mergers and acquisitions and capital markets transactions. Earlier in her career, she served in the United States Department of the Treasury as a member of the Office of International Tax Counsel, where she negotiated the first income tax treaty between the United States and China.
Ms. Wold has served on a number of boards of both for-profit and non-profit organizations. She currently is a board member of Nucleus RadioPharma, founded by the Mayo Clinic and Eclipse Ventures to ensure cancer patients access to potentially life-saving radiopharmaceuticals. She sits on the executive and investment committees and chairs the audit committee of The Jackson Laboratory, a biomedical research institution dedicated to the discovery of genomic solutions to cancer and other human diseases. She is a board member of the Burke Neurological Institute, a research organization affiliated with Weill Cornell Medicine, and is a member of its executive committee. Previously, Ms. Wold chaired the board of Unilife Corporation, a publicly traded medical device/drug delivery company.
Ms. Wold chaired the board of the Church Benefits Association, an industry trade group of financial and benefits institutions. She served on the board of the historic Trinity Church Wall Street and its investment committee, overseeing its multi-billion dollar investment portfolio, and on the executive committee of the board of the Church Divinity School of the Pacific at Berkeley.
Ms. Wold is a member of the Women’s Forum of New York, Women Corporate Directors, and DirectWomen, an organization of women on corporate boards.
A native of North Dakota, Ms. Wold attended Hamline University in St. Paul, Minnesota, from which she graduated summa cum laude and was elected a member of Phi Beta Kappa. She graduated cum laude from the University of Michigan Law School. She holds an honorary degree of Doctor of Humane Letters from the Berkeley Divinity School at Yale University.